ASP-II: Ancrod Stroke Program: Ancrod (Viprinex™) for the Treatment of Acute, Ischemic Stroke

Mise à jour : Il y a 4 ans
Référence : NCT00300196

Femme et Homme

Extrait

The primary purpose of this study is to determine whether a brief intravenous infusion of ancrod started within 6 hours of stroke onset improves functional outcome at 3 months.


Critère d'inclusion

  • Stroke ,Cerebral Ischemia ,Brain Infarction


Liens